Dr Ferruccio De Lorenzo

Dr De Lorenzo is a Consultant Physician at the Lipid Disorders & Cardiovascular Disease Prevention Clinic Imperial College Healthcare NHS Trust Hammersmith Hospital. Prior to this, he was a Consultant Physician in General Medicine and Prevention of Vascular Disorders at Chelsea and Westminster Hospital NHS Foundation Trust. He has published more than 50 articles in International medical journals, and co-authored and edited chapters for several books related to the diagnosis and treatment of cardiovascular disease. In 2015 has been awarded a SHAPE USA (Society for heart attack prevention and eradication) specialist certificate.In 2016 has been awarded a Fellowship from the British & Irish Hypertension Society. In 2020, he was awarded a Fellowship from the Royal College of Physicians.

EXPERT COLUMNIST
Ibero-American Society of Scientific Information on Medical and Healthcare (SIIC)

MEMBER OF THE ADVISORY & EDITORIAL BOARD
Advances in Therapy- international peer-reviewed journal dedicated to the rapid publication of studies in clinical medicine, including research on existing drugs and drugs in development across a range of therapeutic areas. (Springer Healthcare Communications)
Cardiovascular Disorders and Medicine (http://oatext.com/Cardiovascular-Disorders-and-Medicine-CDM.php)
Trends in Medicine and Therapeutics (TMT)

REFEREE TO:
MRC- Medical Research Council (reviewer international grant applications)
QJM- Monthly Journal of the Association of Physicians
Journal of Thrombosis and Haemostasis
Annals of Internal Medicine
Archives of Internal Medicine
International Journal of Cardiology
Arteriosclerosis, Thrombosis & Vascular Biology ATVB
Current HIV Research
Southern Medical Journal
Archives of Medical Research
Journal of Acquired Immune Deficiency Syndromes (JAIDS)
HIV/AIDS - Research and Palliative Care
Advances in Therapy
Vascular health and risk management

Key published papers:
Evidence-based cardiovascular disease prevention. Cardiovascular Disorders and Medicine 2017; 2 (2): 1-2
De Lorenzo F, Feher M, Martin J, Collot-Teixeira S, Dotsenko O, McGregor J. Statin Therapy: Evidence beyond lipid lowering contributing to plaque stability. Curr Med Chem 2006; 13: 3385-93
De Lorenzo F. UK screening plans. The Lancet 2008; 372: 447-8
De Lorenzo F. Evidence-based screening to prevent and control cardiovascular disease worldwide. Editorial, Int J Clin Pract. 2014 May;68(5):534-5
De Lorenzo F. Cardiovascular disease primary prevention failure: A sixth of patients with a QRISK2 score below 10% were started on statins, despite the guidelines-Expert Opinion. Trends In Medicine 2017 (November 10); 17: DOI: 10.15761/TiM.1000101